 | Up a level |
Journal Article
Frenken, P., Hartung, H-P., Olsson, T., Adams, O. and Warnke, C. (2017). Type 0 blood group associates with higher anti-JCV antibody levels. Mult. Scler. J., 23. S. 918 - 920. LONDON: SAGE PUBLICATIONS LTD. ISSN 1477-0970
Garcia Borrega, J., Heindel, K., Kochanek, M., Warnke, C., Stemmler, J., von Bergwelt-Baildon, M., Liebregts, T. and Boell, B. (2021). The critically ill CAR T-cell patient Relevant toxicities, their management and challenges in critical care. Med. Klin.-Intensivmed Notfallmed., 116 (2). S. 121 - 129. HEIDELBERG: SPRINGER HEIDELBERG. ISSN 2193-6226
Goereci, Y., Schweitzer, F., Wellstein, A., Silling, S., Borchmann, S., von Tresckow, B., Adams, O., Martin, R., Schlamann, M., Schroeter, M., Fink, G. R., Wattjes, M. P. and Warnke, C. (2020). Clearance of JC polyomavirus from cerebrospinal fluid following treatment with interleukin-2 and pembrolizumab in an individual with progressive multifocal leukoencephalopathy and no underlying immune deficiency syndrome. Eur. J. Neurol., 27 (11). S. 2375 - 2378. HOBOKEN: WILEY. ISSN 1468-1331
Heesen, C., Mokry, C., Salmen, A., Hegen, H., Maurer, M., Warnke, C., Gehring, K., Berthele, A. and Meier, U. (2022). German guideline for diagnosis and treatment of multiple sclerosis-a survey focusing neurologists in daily practise. Mult. Scler. Relat. Disord., 63. OXFORD: ELSEVIER SCI LTD. ISSN 2211-0356
Ladwig, A., Suh, J., Schweitzer, F., Roeth, P., Remke, G., Warnke, C., Schroeter, M., Izquierdo-Alvarez, E., Bonmann, E., Fink, G. R., Pallasch, C. and Lehmann, H. (2020). Alemtuzumab induces changes in the innate immune system in patients with relapsing-remitting multiple sclerosis. Mult. Scler. J., 26 (3_SUPPL). S. 259 - 260. LONDON: SAGE PUBLICATIONS LTD. ISSN 1477-0970
Mokry, C., Warnke, C., Gehring, K., Hegen, H., Salmen, A., Kraemer, M., Kleiter, I, Fasshauer, E., Scheiderbauer, J., Luehmann, D., Koepke, S., Berthele, A. and Heesen, C. (2022). Implementation study of the 2021 German guideline for diagnosis and treatment of multiple sclerosis. Mult. Scler. Relat. Disord., 57. OXFORD: ELSEVIER SCI LTD. ISSN 2211-0356
Schneider, A., Fasshauer, E., Scheiderbauer, J., Warnke, C., Koepke, S., Kasper, J., Toussaint, M., Temmes, H., Hemmer, B., Schiffmann, I, Rahn, A. C. and Heesen, C. (2022). Development and evaluation of evidence-based patient information handbooks about multiple sclerosis immunotherapies. Mult. Scler. Relat. Disord., 60. OXFORD: ELSEVIER SCI LTD. ISSN 2211-0356
Schweitzer, F., Ladwig, A., Laurent, S., Schroeter, M., Goelz, S., Wieland, U., Silling, S. and Warnke, C. (2020). Is the gut a relevant reservoir for persistent jcpyv infection? Mult. Scler. J., 26 (3_SUPPL). S. 286 - 288. LONDON: SAGE PUBLICATIONS LTD. ISSN 1477-0970
Schweitzer, F., Laurent, S., Fink, G. R., Barnett, Michael H., Hartung, H. P. and Warnke, C. . Effects of disease-modifying therapy on peripheral leukocytes in patients with multiple sclerosis. J. Neurol.. HEIDELBERG: SPRINGER HEIDELBERG. ISSN 1432-1459